Case Study: Stage III Triple Negative Breast Cancer Treatment
Dr. Prato and Dr. Oertle review a triple negative invasive ductal carcinoma breast cancer case discussed in Envita's molecular tumor board. Triple negative breast cancers are very difficult to treat and are often more aggressive than other forms of breast cancer. This particular form of cancer can lead to progression of disease if not approached correctly.
Learn how Envita Medical Center's advanced precision oncology was deployed to help this patient respond to care.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
